Comprehensive Study Guide on Restrictive Cardiomyopathy

Overview and Definition of Restrictive Cardiomyopathy

  • Definition of RCM: Restrictive Cardiomyopathy (RCM) is defined as a rare form of heart muscle disease characterized by restrictive filling of the ventricles.
  • Characteristics of Filling: The relaxation or filling phase of the heart in this condition is considered highly abnormal.
  • Physiological Cause: The heart muscle becomes stiff and poorly compliant, which prevents the ventricular chambers from filling with blood normally.
  • Systolic Function: In the early stages, the Left Ventricular (LV) systolic function remains essentially normal.
  • Prevalence: RCM is the least common form among all cardiomyopathies. It is rare but can occur in young individuals.

Etiology and Classification

  • Most Frequent Causes:
    • Infiltrative Diseases: Amyloidosis (the most common cause), Hemochromatosis, and Sarcoidosis.
    • Metabolic Storage Diseases: Glycogen storage disease and Fabry Disease.
    • Idiopathic: Cases where the primary cause is unknown.
  • Less Common Forms:
    • Endomyocardial fibrosis associated with hypereosinophilic syndrome.
    • Carcinoid syndrome.
    • Metastatic malignancy.
    • Post-radiation or drug-induced cardiomyopathy.

Pathophysiology and Morphological Features

  • Morphological Motto: "Normal Size, Stiff Muscle."
  • Ventricular Dimensions:
    • LV size remains normal.
    • LV volume is generally preserved.
  • Systolic vs. Diastolic Function:
    • LV Systolic Function (Ejection Fraction): Usually normal.
    • LV Diastolic Function: Severely impaired due to stiffness.
  • Atrial Status: The atria (Left Atrium and Right Atrium) are typically enlarged (biatrial enlargement).
  • Progression of Pathophysiology:
    • Heart Failure with Preserved Ejection Fraction (HFpEF): Also known as Diastolic Heart Failure.
    • Primary Dysfunction: Abnormal ventricular filling leads to increased Left Ventricular End-Diastolic Pressure (LVEDPLVEDP), which subsequently causes dilated atria.
    • Later Stages: Eventually, the disease may progress to impaired LV systolic function and reduced Ejection Fraction (EFEF).

2D Echocardiographic Features

  • Biatrial Enlargement: Significant expansion of both the left and right atria.
  • Ventricular Volumes: LV volumes are preserved.
  • Systolic Function: LV systolic function is preserved during the early stage.
  • Inferior Vena Cava (IVC): The IVC appears dilated.
  • Valvular Findings: Homogenous Atrioventricular (AV) valve thickening.
  • Pericardial Findings: A small Pericardial Effusion (PE) may be present.

M-Mode Echocardiography Procedure and Findings

  • Procedural Steps (Normal Values Assessment):
    • Step 1: Obtain a clear Parasternal Long Axis (PLAX) view.
    • Step 2: Select M-Mode button.
    • Step 3: Place the cursor to pass through the Interventricular Septum (IVSIVS), LV cavity, and Posterior Wall (PWPW).
    • Step 4: Keep the cursor at the chordal level, just below the mitral valve leaflets.
    • Step 5: Record the M-mode tracing and freeze the image.
    • Step 6: Measure IVSdIVSd, LVIDdLVIDd, LVIDsLVIDs, and PWdPWd.
    • Step 7: Assess LV function (Machine calculates Fractional Shortening (FS%FS\%) and Ejection Fraction (EFEF)).
  • Normal Adult Values for M-Mode:
    • LVIDdLVIDd (LV Internal Diameter in Diastole): 3.9−5.9 cm3.9 - 5.9\,cm
    • LVIDsLVIDs (LV Internal Diameter in Systole): 2.0−4.0 cm2.0 - 4.0\,cm
    • IVSdIVSd (Interventricular Septum in Diastole): 0.6−1.0 cm0.6 - 1.0\,cm
    • PWdPWd (Posterior Wall Thickness in Diastole): 0.6−1.0 cm0.6 - 1.0\,cm
    • FS%FS\% (Fractional Shortening): 25−45 %25 - 45\,\%
    • LVEFLVEF (Left Ventricular Ejection Fraction): 55−70 %55 - 70\,\%
  • RCM-Specific M-Mode Findings:
    • Lack of septal bounce.
    • Myocardial hypertrophy (increased wall thickness).

Doppler Assessment: MR and TR

  • Mitral Regurgitation (MR):
    • Assessed using Continuous Wave (CW) Doppler.
    • Used to calculate LV dp/dtdp/dt.
    • MR can occur due to leaflet or papillary muscle involvement.
    • Diastolic MR: May occur due to significantly increased LV end-diastolic pressure.
  • Tricuspid Regurgitation (TR):
    • Assessed using CW Doppler to determine Pulmonary Artery Systolic Pressure (PASPPASP).
    • Formula: PASP=4×(TR velocity)2PASP = 4 \times (\text{TR velocity})^2
    • TR can be secondary to pulmonary hypertension.

Diastolic Function Assessment (PW Doppler)

  • Pulse Wave (PW) Doppler Measurement:
    • Obtain Apical 4-Chamber (A4CA4C) view.
    • Place sample volume (2−5 mm2 - 5\,mm) at the tips of the mitral valve leaflets.
    • Record E wave (early filling) and A wave (atrial filling).
  • Normal Diastolic Parameters:
    • E/AE/A Ratio: 1.0−2.01.0 - 2.0
    • Deceleration Time (DTDT): 160−240 ms160 - 240\,ms
  • RCM-Specific Diastolic Findings (Grade III Restrictive):
    • E/AE/A Ratio: >2.0> 2.0
    • Deceleration Time (DTDT): <160 ms< 160\,ms (specifically less than 140 ms140\,ms in early stages transition to restrictive).
    • Characteristics: Large E wave and small A wave.
  • Tricuspid Inflow (PW Doppler):
    • Shows restrictive filling pattern.
    • Increased E/AE/A ratio (>2.1> 2.1).
    • Short DTDT (<120 ms< 120\,ms).

Tissue Doppler Imaging (TDI) for Diastolic Function

  • Measurement:
    • Sample volume (2−5 mm2 - 5\,mm) placed at the medial mitral annulus (septal side) in A4CA4C view.
    • Recording includes S′S' (systolic), E′E' (early diastole), and A′A' (late diastole) waves.
  • RCM-Specific TDI Findings:
    • E′<8 cm/sE' < 8\,cm/s.
    • Markedly diminished diastolic motion.
    • E/E′E/E' ratio serves to assess filling pressures; it increases progressively as the disease stages advance.
    • E/E′>14−15E/E' > 14 - 15 indicates elevated LV filling pressure (Grade II/III).

Venous Flow Analysis

  • Pulmonary Venous Flow:
    • Waves: SS wave (systolic forward flow), DD wave (diastolic forward flow), and ArAr wave (atrial reversal).
    • RCM Findings: Dilated pulmonary veins and a "Blunted SS wave" resulting from increased LA and LV pressures.
  • Hepatic Vein Flow:
    • Reflects changes in pressure, volume, and compliance of the right atrium.
    • RCM Findings: Dilated Hepatic veins and a dilated Inferior Vena Cava (IVCIVC).
    • Waveform identifies SS, DD, and AA waves similar to pulmonary veins, reflecting RA status.

Cardiac Amyloidosis

  • Pathology: The most common cause of RCM, resulting from the deposition of amyloid fibrils in organs.
  • Involvement: Can involve the myocardium, valves, interatrial septum, and pericardium.
  • Echocardiographic Features of Amyloidosis:
    • Increased thickness of both LV and RV walls.
    • Normal or small LV cavity size.
    • Thickened atrial septum.
    • Pericardial effusion (in advanced disease).
    • Spectrum of diastolic dysfunction.
    • Thickening of valves and presence of multivalvular regurgitation.

Differential Diagnosis: RCM vs. Constrictive Pericarditis

FeatureRestrictive Cardiomyopathy (RCM)Constrictive Pericarditis
PericardiumNormalThickened
Left VentricleSmall, no septal bounceSmall, septal bounce present (+/+)
AtriaDilatedNormal
Mitral InflowIncreased E/AE/A, Short DTDT, No respiratory variationIncreased E/AE/A, Short DTDT, >25%>25\% expiratory variation in E velocity
Mitral Annulus TDIE′<8 cm/sE' < 8\,cm/sMedial E′>8 cm/sE' > 8\,cm/s; Medial E′E' larger than lateral E′E'
MR / TRFrequent TR>MRTR > MRInfrequent
Pulmonary Vein InflowDecreased S/DS/D ratio; prominant Atrial reversalBlunted S/DS/D ratio; Decrease in SS and DD wave with inspiration
Hepatic VeinInspiration: minimal increase in SS and DD velocityExpiration: decreased diastolic flow; increase in reversals >25%>25\%
PA Pressure>40 mmHg> 40\,mmHg<40 mmHg< 40\,mmHg
VpV_p (Color M-mode)Decreased Vp<45 cm/secV_p < 45\,cm/secNormal or increased >100 cm/s> 100\,cm/s